Dr. Moises Dominguez, MD

Dr. Dominguez practices at Columbia University Irving Medical Center in New York, New York.

Dr. Dominguez's NPI, 1033607171, was assigned on April 24, 2018. Dr. Dominguez graduated from Yale School of Medicine in 2018. Dr. Dominguez holds New York license 316826.

Dr. Dominguez's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Dominguez's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Dominguez is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Dominguez to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dominguez practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dominguez's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dominguez is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Dominguez is licensed in New York.

Dmand AI lists migraine and chronic headache among the conditions Dr. Dominguez treats.

CMS data shows 5,007 Medicare services from Dr. Dominguez across 7 procedure codes in 2024, for 107 Medicare patients. Medicare paid $50,126 for them. Every service was in an office.

CMS counts 107 Medicare patients who saw Dr. Dominguez in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high cholesterol, and 62% have arthritis. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dominguez's median patient age at 44, with 77% women.

In 2024, Dr. Dominguez wrote 384 Medicare Part D claims for 95 patients. 70% of them were for generic drugs. CMS names the drug for 310 of them, across 14 drugs with 11 or more claims each, at $140,187 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dominguez for performance year 2024, reported through an alternative payment model (APM). Dr. Dominguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dominguez as offering telehealth.

Dmand AI links 14 papers to Dr. Dominguez, published from 2014 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Chronic Pain, Headache Disorders and Pain Management. Dr. Dominguez has published most often in Curr Pain Headache Rep. Dr. Dominguez's most frequent co-authors are Sait Ashina, MD, Jamal J. Hasoon, MD and Daniel Jung Pak, MD.

CMS Open Payments shows 13 general payments to Dr. Dominguez from 4 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,060.

Dmand AI lists 1 award for Dr. Dominguez, most recently Neurology Resident Teaching Award in 2022.

Dr. Dominguez graduated from Yale School of Medicine in 2018. Dr. Dominguez is a member of AAN.

Dr. Dominguez is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.